<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00449059</url>
  </required_header>
  <id_info>
    <org_study_id>Nitrate_USZ04</org_study_id>
    <nct_id>NCT00449059</nct_id>
  </id_info>
  <brief_title>Nitrate and Hypertension in Heart Transplanted Patients</brief_title>
  <official_title>Acute Effect of Nitroglycerin on Cyclosporine-Induced Hypertension After Cardiac Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to evaluate the acute effect of nitroglycerine infusion on blood&#xD;
      pressure and heart rate in heart-transplanted patients with cyclosporine-induced&#xD;
      hypertension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Cyclosporine represents a milestone in immunosuppression after organ&#xD;
      transplantation. Its use, however, comes at the cost of significant side effects, such as&#xD;
      arterial hypertension. Our aim was to investigate the effect of acute administration of&#xD;
      nitroglycerin in heart-transplanted patients with cyclosporine-induced hypertension.&#xD;
&#xD;
      Methods: We included 18 hypertensive patients (HT) scheduled for elective cardiac&#xD;
      catheterization after heart transplantation and treated with cyclosporine, as well as&#xD;
      6-matched HT. Simultaneous measurements of BP in the aorta and pulmonary artery before and&#xD;
      after administration of nitroglycerin were done.&#xD;
&#xD;
      Results: After injection of 50μg and 100μg nitroglycerin a significant BP decrease was&#xD;
      observed both in heart-transplanted patients (sBP p=0.0001; dBP p=0.0001) and in controls&#xD;
      (sBP p=0.006; dBP p=0.05). This reduction was more pronounced in heart-transplanted patients&#xD;
      (sBP p=0.022; dBP 0.018 for group comparison). 8±3 minutes after the last nitrate infusion BP&#xD;
      remained significantly reduced vs baseline in heart-transplanted patients (p&lt;0.001) while it&#xD;
      comes back to baseline in controls. The reduction in sBP (p=0.04 after 50μg nitroglycerin;&#xD;
      p=0.05 after 100μg nitroglycerin) but not dBP correlated to cyclosporinemia.&#xD;
&#xD;
      Conclusions: This study indicates that nitroglycerin reduces sBP in heart-transplanted&#xD;
      patients with cyclosporine-induced hypertension. Further studies are needed to evaluate the&#xD;
      long-term effect of nitrates in these patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure reduction after acute nitroglycerine infusion</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate modification after acute nitroglycerine infusion</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>Hypertension</condition>
  <condition>Heart Transplantation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acute infusion of nitroglycerine into the pulmonary artery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Heart-transplanted group:&#xD;
&#xD;
          -  Patients with hypertension and treated with cyclosporine&#xD;
&#xD;
          -  Patients under optimal standard therapy&#xD;
&#xD;
          -  Patients giving written informed consent&#xD;
&#xD;
        Control group:&#xD;
&#xD;
          -  Patients with hypertension&#xD;
&#xD;
          -  Patients without prior transplantation of any kind&#xD;
&#xD;
          -  Patients giving written informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Hypertensive patients receiving immunosuppressive drugs&#xD;
&#xD;
          -  Patients receiving any kind or nitrate derivates&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto Corti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>CH8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>March 15, 2007</study_first_submitted>
  <study_first_submitted_qc>March 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2007</study_first_posted>
  <last_update_submitted>March 15, 2007</last_update_submitted>
  <last_update_submitted_qc>March 15, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2007</last_update_posted>
  <keyword>heart transplantation</keyword>
  <keyword>cyclosporine</keyword>
  <keyword>hypertension</keyword>
  <keyword>nitroglycerin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

